share_log

Capital One Initiates Coverage On GlycoMimetics With Overweight Rating, Announces Price Target of $12

Capital One Initiates Coverage On GlycoMimetics With Overweight Rating, Announces Price Target of $12

Capital One 以增持评级启动对 GlycoMimetics 的报道,宣布目标股价为12美元
Benzinga ·  2023/12/22 06:09

Capital One分析师Zegbeh Jallah以增持评级开始对GlycoMimetics(纳斯达克股票代码:GLYC)进行报道,并宣布目标股价为12美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发